Nit-Fit Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year, 5 Months
- Last Filing with ROC 31 Mar 2011
- Open Charges ₹ 3.50 M
About Nit-Fit Remedies
Nit-Fit Remedies Private Limited (NRPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 August 2005 and has a history of 19 years and five months. Its registered office is in Cuttack, Odisha, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2011. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.50 M.
Nitai Nanda and Basanti Nanda serve as directors at the Company.
Company Details
-
Location
Cuttack, Odisha, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51397OR2005PTC008318
-
Company No.
008318
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Aug 2005
-
Date of AGM
30 Sep 2011
-
Date of Balance Sheet
31 Mar 2011
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
What products or services does Nit-Fit Remedies Private Limited offer?
Nit-Fit Remedies Private Limited offers a wide range of products and services, including Antibiotic Tablets & Capsules, Azithromycin Tablets.
Who are the key members and board of directors at Nit-Fit Remedies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitai Nanda
|
Director | 25-Aug-2005 | Current |
|
Basanti Nanda
|
Director | 25-Aug-2005 | Current |
Financial Performance of Nit-Fit Remedies.
Enhance accessibility to Nit-Fit Remedies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nit-Fit Remedies?
Unlock access to Nit-Fit Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹3.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.25 Cr
- The Federal Bank Ltd : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Mar 2017 | Others | ₹2.50 M | Open |
| 26 Jul 2006 | The Federal Bank Ltd | ₹1.00 M | Open |
How Many Employees Work at Nit-Fit Remedies?
Unlock and access historical data on people associated with Nit-Fit Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nit-Fit Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nit-Fit Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.